ABSTRACT
INTRODUCTION
Aflatoxins (AFs) are secondary toxic fungal metabolites produced by Aspergillus flavus and Aspergillus parasiticus. There are four naturally occurring AFs which are structurally similar compounds namely AFB 1 , AFB 2 , AFG 1 , AFG 2 , the most hepatotoxic being AFB 1 . Aflatoxins not only contaminate our food stuffs but are also found in edible tissues, milk and eggs after consumption of contaminated feed by farm animals (1,2) . Epidemiological and experimental studies have shown that AFs are hepatotoxic, hepatocarcinogenic, mutagenic and teratogenic (3) . The liver is the primary site for biotransformation of ingested AFB 1 . The parent molecule is harmless, but in the liver it is converted by members of the cytochrome P450 (CYP 450) super-family to AFB 1 -8,9-epoxide. Epoxidation of AFB 1 to the exo-8, 9-epoxide is a critical step in the genotoxic pathway of this carcinogen. The epoxide is highly unstable and binds with high affinity to guanine bases in DNA to form aflatoxin-N7-guanine (4, 5) . The aflatoxin-N7-guanine has been shown to be capable of forming guanine (G) to thymine (T) transversion mutations in DNA which is regarded as a critical step in the initiation of AFB 1 -induced hepatocarcinogenesis (3, 6) . Generation of intracellular reactive oxygen species (ROS) occurs during the metabolic processing of AFB 1 by CYP 450 in the liver (7) . These species may attack soluble cell compounds resulting in damage to critical cellular macromolecules including lipids and proteins leading to the impairment of cell functioning and cytolysis. Peroxidation of membrane lipids initiates loss of membrane integrity, membrane bound enzyme activity and cell lysis (8) . Malondialdehyde (MDA) is a product generated during the oxidative breakdown of lipids, and is found either in free form, or bound to certain tissue structures (9) . Peroxidative damage induced in the cells is encountered by elaborate defense mechanisms, including enzymatic and non-enzymatic antioxidants (10) . The liver has been found to be the main site of these scavenger enzymes (11) . Selenium is an essential trace element. Low selenium status may contribute to the etiology of different disease conditions (12) . Epidemiological studies have suggested an inverse relationship between Se levels and different cancers (13) . Decreased Se levels were found in HBV and HCV infections, intrahepatic cholestasis, post-viral or alcoholic cirrhosis and hepatocellular carcinoma (14,15) . Vitamin C is a water-soluble chain breaking antioxidant, as it scavenges free radicals and reactive oxygen molecules, which are produced during metabolic pathways of detoxification. It also prevents formation of carcinogens from precursor compounds (16) . Tocopherol and glutathione also rely on vitamin C for regeneration back to their active isoforms. The relationship between vitamin C and glutathione is unique. Vitamin C reduces glutathione back to the active form and glutathione once reduced, it will regenerate vitamin C from its dehydroascorbic acid (DHAA) or oxidized state. Also, it acts as an electron donor for different enzymes (17) . Glutathione pathway has been also shown to play a major role in the detoxification of AFB 1 . Part of the enzyme is secreted into the circulation bound to HDL, where the rest is stored in the liver. The physiologic role played by PON 1 in liver is suggested to be the protection against oxidative stress (22) . The aim of the present study was to highlight the antagonistic effect of the exogenous antioxidants Se and vitamin C against the hepatotoxic effect of AFB 1 because they have a role in prevention of formation of carcinogens from precursor compounds and they are natural antioxidants.
MATERIALS & METHODS
The current study was carried out on 85 white male albino rats of approximately 120 -150 g body weight which were housed in wire mesh cages and were fed standard rat chew and allowed free access to water. They were kept under constant environmental conditions (25 <C and 12 h dark light cycle). The studied animals were divided into: *Group I (control group): 10 rats received I.P injection of dimethylsulfoxide (DMSO) (The solvent for AFB 1 ) in a dose of 0.5ml for 15 days. *Group II: 45 rats received I.P injection of AFB 1 in a dose of 0.25 mg/kg body weight dissolved in DMSO in a volume of 0.5 ml for 15 days. This group was subdivided into three equal subgroups after the end of injection period as follows; Group IIa: received regular diet without antioxidants. Group IIb: received Se orally in a dose of 0.2 mg/kg body weight for 15 days. Group IIc: received vitamin C orally in a dose of 200 mg/kg body weight for 15 days. *Group III: 15 rats given selenium orally in a dose 0.2 mg/kg body weight for 15 days during and 15 days after AFB 1 injection. *Group IV: 15 rats given vitamin C orally in a dose 200 mg/kg body weight for 15 days during and 15 days after AFB 1 injection.
At the end of the experiment, 10 rats were died, six rats from group II, two from group III and the remaining two from group IV.
The doses of AFB 1 , Se and vitamin C were chosen on the basis of the previous studies (23-25) . All experiments were carried out according to the guidelines of the Ethical Committee of Tanta University, Faculty of Medicine.
Sample collection: All rats were sacrificed and blood samples were collected. Sera were separated and stored in aliquots at -70 ○ C till used for different estimations.
Then, the abdomen and the thorax were opened and livers were removed, washed three times in ice cold saline and blotted individually on ash-free filter paper, used for preparation of tissue homogenates.
Preparation of tissue homogenates:
Each liver is then divided into two specimens. One piece was kept in 10% formalin solution and fixed for histopathological examination, and the remaining one was stored at -70 ºC till use.
Tissue samples were divided into three parts. Specimens were weighted and homogenized with a PotterElvenhjem tissue homogenizer (20-30 up and-down strokes). One part was homogenized in phosphate buffer saline (PBS) 50 mM (pH 7.4) for estimation of protein content, GST activity and GSH level, the second was homogenized in potassium phosphate buffer10 mM (pH 7. 4 
STATISTICS:
Statistical data and analyses used in the present study were conducted, using range, the mean, standard deviation, analysis of variance [ANOVA] test followed by Tukey's post hoc test and linear correlation coefficient.
RESULTS
The present study showed significant increase of serum AST and ALT enzymes activities with decrease of serum albumin level and non significant change of total protein level (table 1) . Serum and tissue MDA levels showed statistically significant increase in group IIa in comparison to their levels in group I (control group) (P<0.001). Their levels in group IIb and group IIc showed no significant difference when compared to their levels in group IIa and also when compared to each other (P>0.05). But their levels in both groups were significantly higher than the control group (P<0.001).Their levels in group III and group IV showed statistically significant decrease when compared to group IIa, group IIb and group IIc (P<0.001), with no significant difference between them and control group (P>0.05). Also, there was no significant difference between each other (P>0.05), (tables 2A and 2B).
Two endogenous antioxidants were studied, an enzyme GST and a non enzyme GSH. The two behaved differently. Serum and tissue GST enzyme activity showed statistically significant increase in group IIa in comparison to their activities in group I (control group) (P<0.001). The activity in group IIb and group II c showed no significant difference when compared to group II a and also when compared to each other (P>0.05). But the activity in both groups was significantly higher than the control group (P<0.001). Both serum and tissue GST activity showed statistically significant decrease in both group III and group IV when compared to group IIa, group IIb and group IIc (P< 0.001), with no significant difference between them and control group (P>0.05). Also, there was no significant difference between each other (P>0.05) (tables 3 A and 3 B).
Serum and liver GSH showed significant decrease in group IIa in comparison to their levels in group I (control group) (P <0.001). Their levels in group IIb and group IIc showed no significant difference when compared to their levels in group IIa and also when compared to each other (P>0.05). But their levels in both groups were significantly lower than the control group (P <0.001). In groups III and IV their levels showed significant increase when compared to group IIa, group IIb and group IIc (P<0.001), with non significant difference between them and control group (P>0.05). Also, the difference between each other was insignificant (P>0.05, tables 4 A & 4B).
The activity of both serum and tissue PON1 showed statistically significant decrease in group IIa in comparison to their activities in control group (P< 0.001). Their activity in group IIb and group IIc showed no significant difference when compared to group IIa (P>0.05). But the activity in both groups was significantly lower than the control group (P< 0.001). Their activity in group III and group IV showed statistically significant increase when compared to group IIa, group IIb and group IIc (P< 0.001), with no significant difference between them and control group (P>0.05). Also, there was no significant difference between each other (P>0.05) (tables 5A and 5B).
As regards correlation matrix in the present study, there were negative correlation between serum and tissue MDA levels and serum and tissue GSH levels in all studied groups (r = -0.708, P< 0.001, r = -0.938 ,P< 0.001 respectively).
Also, negative correlation was found between serum and tissue MDA levels and serum and tissue PON1 activity in all studied groups (r = -0.661, r = -0.738 respectively, P< 0.001 for each). Positive correlation was found between serum and tissue MDA levels with serum and tissue GST activity in all studied groups. (r = 0.724, r= 0.897 respectively P< 0.001 for each), (tables 6 and 7).
Histopathological results in the present study showed no changes in the gross and histological appearance of the livers of the rats from control group, as shown in Fig 1. However, the livers of group IIa (AFB 1 -treated group) were slightly pale, enlarged and grayish mottled in gross appearance. In addition, severe histopathological changes were observed in livers of all the rats from AFB 1 -treated group. The predominant lesions were extensive vacuolar (hydropic) degeneration, in which the cytoplasm of hepatocyte contains many vacuoles with irregular border. These changes were seen in almost all lobules, and were more pronounced in centrilobular and intermediate areas.
Most hepatocytes in the degenerative and necrotic regions had pycnotic nuclei, and were so swollen that several cells had ruptured. The sinusoids were shrunken or completely plugged due to swollen hepatocytes. In addition, some hepatocytes in the periportal regions had moderate to severe cytoplasmic vacuolation, indicating fatty change. In addition, some cases showed bile duct hyperplasia with focal area of necrosis and inflammatory infiltrate. Because of all these changes the normal architecture of the hepatic parenchyma was distorted. However, the livers of all animals showed no cirrhotic changes (Fig.2 A, B) .
Group IIb (rats given selenium after AFB 1 injection) and group IIc (rats given vitamin C after AFB 1 injection) showed no significant difference in comparison to AFB 1 injected group (Fig. 3&4) .
In group III and IV, Se and vitamin C supplementation with and after AFB 1 injection ameliorated or reversed the changes induced by AFB 1 in part (Fig. 5&6) . The lesions in the liver of rats in both groups were conspicuously less than those in the rats that received AFB 1 only. The livers from the rats in these groups showed no extensive hydropic degeneration or necrotic changes.
Moreover, the architecture of lobules was not disrupted and the hepatocytes mostly had normal appearance, however only few lobules of two livers showed a focus of degenerative cells, most of which had normal nuclear appearance and mild cytoplasmic degeneration. Group IIb: Selenium orally after AFB1 injection (no=14). Group IIc: Vitamin C orally after AFB 1 injection (no=12). Group III: Selenium orally during and after AFB 1 injection (no=13). Group IV: Vitamin C orally during and after AFB 1 injection (no=13). Group IIb: Selenium orally after AFB1 injection (no=14). Group IIc: Vitamin C orally after AFB 1 injection (no=12). GroupIII: Selenium orally during and after AFB 1 injection (no=13). Group IV: Vitamin C orally during and after AFB 1 injection (no=13). 
injected group (no=13).
Group IIb: Selenium orally after AFB1 injection (no=14). Group IIc: Vitamin C orally after AFB 1 injection (no=12). Group III: Selenium orally during and after AFB 1 injection (no=13). Group IV: Vitamin C orally during and after AFB 1 injection (no=13). 
injected group(no=13).
Group IIb: Selenium orally after AFB1 injection (no=14). Group IIc: Vitamin C orally after AFB 1 injection (no=12). Group III: Selenium orally during and after AFB 1 injection(no=13). Group IV: Vitamin C orally during and after AFB 1 injection (no=13). 
DISCUSSION
Aflatoxins (AFs) are a group of mycotoxins of difuranocoumarin derivatives produced by Aspergillus flavus and A. parasiticus. The most hepatotoxic being AFB 1 and is usually predominant in foods (2) . Aspergilli are common in nature, and can colonize and contaminate various foods and feeds under favorable conditions of temperature and humidity (31) . The main target organ of Afs intoxication is the liver, and acute toxic hepatitis with high mortality rate has been reported (3,32) . In addition, in humans adverse effects in immune system (33) , and gastrointestinal tract have been shown (34) . Other effects have been described, as interference with metabolic processes of various essential micronutrients (33) . An assessment of the health risk possibly related to AFs exposure is difficult as the toxicokinetics in humans is complex and knowledge is incomplete. In addition to intensity and duration of exposure, several factors, such as age and health conditions, seem to influence susceptibility to AFs effects (35) . So, it is easier to asses this in experimental animal models.
The aim of the present study was to highlight on the antagonistic effect of the exogenous antioxidants Se and vitamin C against the hepatotoxic effect of AFB l because they have a role in prevention of formation of carcinogens from precursor compounds and they are natural antioxidants.
Aflatoxin B 1 toxicity may ensue through the generation of intracellular reactive oxygen species (ROS) during the metabolic processing of AFB 1 by CYP 450 in the liver (7) . Lipid peroxidation is one of the main manifestations of oxidative damage initiated by ROS and it has been linked with altered membrane structure and enzyme inactivation (36) .The increase in lipid peroxides might result from increased production of free radicals and/or a decrease in antioxidant status where it has been implicated in AFB1-induced hepatotoxicity (37) . The present study showed that serum and liver tissue MDA tissue levels were significantly increased in AFB 1 treated rats (group IIa) when compared with control one (group I). The animal groups, receiving Se and vitamin C after AFB 1 treatment (groups IIb and IIc respectively), showed the same increment in MDA levels. Groups III and IV receiving the antioxidants during and 15 days after AFB 1 injections showed decrease of MDA levels back to the control level.
The significant increase in serum and hepatic MDA levels observed in AFB 1 (49) observed the reduction of GST activity in rats treated with AFB 1 and suggested that the GST activity was first stimulated by oxidative stress evoked by AFB 1 and then after several weeks its activity was reduced as a result of AFB 1 hepatotoxicity.
The significant decrease in levels of serum and hepatic GSH in the AFB 1 (51) reported no significant changes in hepatic GSH levels in rats fed AFB 1 contaminated diet for 15 days.
The decrease of GSH level in serum and liver tissue homogenate may be attributed to the conjugation of AFB 1 active metabolite, AFB 1 -8,9 epoxide, with GSH, a reaction that is catalyzed by the induced enzyme GST Selenium and vitamin C had protective effects on both serum and hepatic tissue GST enzyme activity and GSH level only in groups III and IV. Our results showed normalization of hepatic GSH. This is in agreement with the study of Kheir Eldin et al. (2008) (47) , who showed that Se and vitamin E had the same effect.
The decrease of serum and hepatic GST activity in antioxidants treated groups during and after AFB 1 injection (groups III and IV) could be explained by decrease in oxidative stress through the antioxidant properties of Se and vitamin C.
To our knowledge this is the first study of the relation between serum and liver PON1 and AFB 1 hepatic intoxication in experimental rats. Therefore, the results of the present work are compared with those of the hepatotoxin, CCl 4 on PON1 activity.
The present study showed that serum and liver tissue PON1 activity were significantly decreased in AFB 1 injected rats (group IIa) and those having either Se or vitamin C after AFB1 injections (groups IIb and IIc, respectively) in comparison to control group (group I). The two exogenous antioxidants, Se and vitamin C, administrated during and after AFB 1 treatment had a protective effect on PON1 activity, which was back to normal in groups III and IV.
The present study showed that both serum and liver PON1 behaved similarly. A common in-vitro identity of both enzymes is supported by biochemical studies showing properties shared by serum and hepatic PON1, optimum pH, affinity for substrate (Km), heat inactivation and calcium requirement The decreased PON1 enzymatic activity in the intoxicated animals could be due to hepatic dysfunction. Supporting this hypothesis is the observation of an inhibition of microsomal PON1 activity in rats with chronically administered CCl 4 (22) . In a recent study, decreased PON1 activity in sera of patients with chronic liver disease was suggested to be related to the degree of liver damage (54) . Various in-vivo and in-vitro studies in animals and humans have provided evidence that antioxidants can increase PON1 activity, possibly by protecting the enzyme from the oxidative stress-induced inactivation. This supports the present finding that Se and vitamin C caused an increase of PON1 activity in the AFB 1 treated rats ( groups III and IV) to normal control level (group I). Also, it has been showed in human study positive correlation was found between the dietary and medical intakes of vitamin C and PON1 activity (55) . In our work all the studied parameters behaved similarly in both serum and liver tissue in all the studied groups. Se and vitamin C, were only effective when given through out the experiment i.e during and 15 days after AFB 1 administration. They did not cause any significant effect on any of the studied parameters when given only after AFB 1 injection. This may be due to AFB 1 intoxication is caused by AFB 1 8,9 epoxide which form adducts with cellular molecules which are still present few weeks after no dosing of AFB 1 (56) . The two antioxidants were effective in combating lipoperoxidation of hepatocytes as manifested by decreasing the production of MDA. They also caused increase of the endogenous antioxidant GSH to normal level, as well as normalization of the activity of the inducible GST enzyme .They also, caused an increment of PON1 activity to nearly normal value.
In the present study, liver cell damage caused by AFB1 administration was confirmed by the significant elevation of the activity of serum AST and ALT enzymes (groups IIa, IIb and IIc) which may be due to leakage of these cytoplasmic enzymes from liver cells into the blood stream as a result of damage of plasma membranes by lipoperoxidation (57) . Se and vitamin C during and after AFB1 treatment (groups III and IV, respectively) caused significant decrease of serum activities of transaminases. This is because these two antioxidants may have a protective effect on the hepatic cell membrane combating lipoperoxidation.
The serum total protein concentration in all treated groups (II,III,IV) did not show any significant change compared with control group. While serum albumin showed a significant decrease in the treated groups (IIa,IIb,IIc). Se and vitamin C caused increase of serum albumin when given only with and after AFB 1 injection (groups III and IV). The decrease of serum albumin may be explained by decrease of its synthesis by the liver (44) .The discrepancy of the results between total protein and albumin could be because there may be an increase of other serum proteins e.g globulins, that were not determined .
Histopathological study confirmed the biochemical findings in this study. Livers of AFB 1 treated rats showed marked degenerative changes, necrosis and disrupted architecture of hepatic lobules. Selenium or vitamin C-treated animals showed less histopathological abnormalities including hydropic degeneration, bile duct proliferation and peripheral fibrosis as compared with AFB 1 treated rats, thereby confirming their protective role against hepatotoxicity induced by AFB 1 .
Conclusion and Recommendations:
All the above findings confirm the protective role of the two antioxidants studied on the hepatotoxicity caused by AFB 1 .
Because of the protective role of antioxidants selenium and vitamin C against the hepatotoxicity of AFB1 in the present experimental work together with other published studies, it is highly recommended to eat well balanced diets that contain sufficient antioxidants selenium and vitamin C or take antioxidants supplementation daily as a way to counteract deleterious effects of this common hepatotoxin, AFB 1 .
